18 related articles for article (PubMed ID: 19538861)
1. Inhibitory effect of dimeric beta peptide on the recurrence and metastasis of hepatocellular carcinoma in vitro and in mice.
Wang SM; Zhu J; Pan LF; Liu YK
World J Gastroenterol; 2008 May; 14(19):3054-8. PubMed ID: 18494058
[TBL] [Abstract][Full Text] [Related]
2. Synthesized multiple antigenic polypeptide vaccine based on B-cell epitopes of human heparanase could elicit a potent antimetastatic effect on human hepatocellular carcinoma in vivo.
Zhang J; Yang JM; Wang HJ; Ru GQ; Fan DM
PLoS One; 2013; 8(1):e52940. PubMed ID: 23308126
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of heparanase multiple antigenic peptide 2 is associated with poor prognosis in gastric cancer: Potential for therapy.
Zhang J; Yang J; Han X; Zhao Z; DU L; Yu T; Wang H
Oncol Lett; 2012 Jul; 4(1):178-182. PubMed ID: 22807984
[TBL] [Abstract][Full Text] [Related]
4. Screening and identification of novel B cell epitopes in human heparanase and their anti-invasion property for hepatocellular carcinoma.
Yang JM; Wang HJ; Du L; Han XM; Ye ZY; Fang Y; Tao HQ; Zhao ZS; Zhou YL
Cancer Immunol Immunother; 2009 Sep; 58(9):1387-96. PubMed ID: 19169879
[TBL] [Abstract][Full Text] [Related]
5. [Inhibitory effects of recombinant human endostatin on the metastatic potential and invasiveness of hepatocellular carcinoma HCCLM6 cells in vitro].
Zhang PH; Qin J; Li AM; Ding XM; Yang-feng D; Rong-cheng L
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):658-61. PubMed ID: 18495614
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia increases heparanase-dependent tumor cell invasion, which can be inhibited by antiheparanase antibodies.
He X; Brenchley PE; Jayson GC; Hampson L; Davies J; Hampson IN
Cancer Res; 2004 Jun; 64(11):3928-33. PubMed ID: 15173004
[TBL] [Abstract][Full Text] [Related]
7. [Expression of heparanase mRNA and its clinical significance in primary hepatocellular carcinoma].
Zhang YL; Fu ZR; Ding GS; Fu H; Wang YH; Wang Q
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):359-61. PubMed ID: 12921566
[TBL] [Abstract][Full Text] [Related]
8. The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma.
El-Assal ON; Yamanoi A; Ono T; Kohno H; Nagasue N
Clin Cancer Res; 2001 May; 7(5):1299-305. PubMed ID: 11350898
[TBL] [Abstract][Full Text] [Related]
9. [Effects of anti-heparanase antibody on the growth and invasion of HCCLM6 human hepatocellular carcinoma cells].
Han XM; Wang HJ; Yang JM; Zhou YL; Tao HQ; Gao H; Ye ZY
Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):10-4. PubMed ID: 19538861
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
